Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.250
-0.050 (-3.85%)
At close: Mar 6, 2026, 4:00 PM EST
1.294
+0.044 (3.52%)
After-hours: Mar 6, 2026, 6:39 PM EST
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $42.98 million as of March 6, 2026. Its market cap has decreased by -65.46% in one year.
Market Cap
42.98M
Enterprise Value
35.74M
1-Year Change
-65.46%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $42.98M, a decrease of -79.27%. That is a compound annual growth rate of -53.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 42.98M | -6.02% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 45.14M |
| Estrella Immunopharma | 44.98M |
| Apollomics | 43.05M |
| Aligos Therapeutics | 42.95M |
| NextCure | 42.31M |
| Lite Strategy | 41.45M |
| OnKure Therapeutics | 41.32M |
| Palatin Technologies | 40.55M |